학술논문
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
14683083